Table 1.
Baseline personal and clinical characteristics of residents of care homes assigned to focused training and support package or usual care (control). Values are numbers (percentages) of residents unless stated otherwise
| Characteristics | Control homes (n=6; 168 residents) | Intervention homes (n=6; 181 residents) |
|---|---|---|
| Median (range) age (years) | 82 (53-101) | 82 (60-98) |
| Men | 102/168 (61) | 117/181 (65) |
| Taking neuroleptics | 83/167 (50) | 85/181 (47) |
| Median (range) dose of neuroleptic in chlorpromazine equivalents (No of patients) | 100 (12.5-630) (n=83) | 100 (10-1200) (n=84) |
| Taking other psychotropics | 89/168 (53) | 98/181 (54) |
| A least one fall in past 12 months | 98/168 (58) | 101/169 (60) |
| Median (range) Cohen-Mansfield agitation inventory* | 37 (29-118) n=163 | 39 (29-114) n=167 |
| At least one episode of aggression in past 12 months | 26/168 (15.5) | 11/169 (6.5) |
| Clinical dementia rating: | ||
| None, questionable, or mild | 37/163 (23) | 25/170 (15) |
| Moderate | 32/163 (20) | 46/170 (27) |
| Severe | 94/163 (58) | 99/170 (58) |
| Median (range) wellbeing†‡ (No of patients) | 0.9 (-2.5 to 2.6) (n=145) | 0.8 (-1.7 to 2.5) (n=160) |
| Spending some (>0%) time asleep‡ | 111/145 (77) | 124/160 (78) |
| Spending some (>0%) time withdrawn‡ | 98/145 (68) | 103/160 (64) |
*
Range 29-203; higher scores mean more agitation (scores >40 usually accepted as clinically significant).
†
Range -5 to 5.
‡
Estimated using dementia care mapping.